Unsurprisingly, Invo Bioscience Inc. (OTCMKTS:IVOB) lost another 11.46% on Friday, and at this point it looks like this has become the norm for the ticker. This turn of events is hardy surprising for seasoned...
Unfortunately for all the people that were hyped up by its latest announcement, Invo Bioscience Inc. (OTCMKTS:IVOB)’s jump didn’t last. It crashed 10.00% on Friday’s session, and if you take a closer look, similarities...
Invo Bioscience Inc (OTCMKTS:IVOB) exploded up the charts for two sessions in a row after an announcement that the FDA has given it clearance for its INVOcell device. It is rare to see a...
We’ve always maintained that any investment should be based on sufficient and up-to-date information about the company and the stock. Clearly, many people tend to disagree with us. Those people heard yesterday that Invo...
At the end of February, Invo Bioscience Inc (OTCMKTS:IVOB) issued a shareholder update and told investors what they had been up to during the previous few months. They proudly announced that they had been...
The stock of Invo Bioscience Inc (OTCMKTS:IVOB) had been traded in a relatively flat price tunnel since January. Until yesterday, though. Clocking in at $0.45 per share, IVOB jumped 28%, thus hitting a six-month...